Anti-tumour necrosis factor α therapy for ankylosing spondylitis: international experience

The conventional approach to treatment of patients with spondyloarthritis (SpA), particularly ankylosing spondylitis (AS), has serious limitations, adding a sense of urgency to the evaluation of new treatments for these rheumatic disorders. Tumour necrosis factor α (TNFα) is a cytokine that has been...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Braun, J, Sieper, J, Breban, M, Collantes-Estevez, E, Davis, J, Inman, R, Marzo-Ortega, H, Mielants, H
Format: Artigo
Jezik:Inglês
Izdano: 2002
Teme:
Extended Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1766732/
https://ncbi.nlm.nih.gov/pubmed/12381511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.61.suppl_3.iii51
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki